You may also experience nausea, vomiting, fever, or pain that spreads to the shoulder
Clinical studies show that lower doses of GLP-1 agonists are highly effective at reducing hemoglobin A1c (which indicates the average blood sugar level over the past 2-3 months), improving insulin sensitivity, and directly addressing the metabolic dysregulation often associated with estrogen decline and perimenopausal weight gain, helping to stabilize energy levels and reduce fat-storage signaling
In July 2024, the FDA issued an alert about compounded semaglutide
Why it matters: Celebrities sway peoples healthcare choices
The goal is to get more vitamins and minerals per calorie
Other safety concerns include risks of pancreatitis, gallbladder disease, and diabetic retinopathy complications (particularly with semaglutide)